Revolution Medicines Inc

Stock Chart, Company Information, and Scan Results

$189.88(as of Jul 8, 3:59 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Revolution Medicines Inc Company Information, Fundamentals, and Technical Indicators

Stock Price$189.88
Ticker SymbolRVMD
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees883
CountyUSA
Market Cap$40,491.1M
EBIDTA-1,378.4M
10-Day Moving Average185.69
P/E Ratio-27.41
20-Day Moving Average171.32
Forward P/E Ratio0.00
50-Day Moving Average157.68
Earnings per Share-7.10
200-Day Moving Average103.57
Profit Margin-Infinity%
RSI71.97
Shares Outstanding212.6M
ATR7.02
52-Week High193.69
Volume1,884,356
52-Week Low34.00
Most Recent Support Level186.56
Book Value1,499.9M
Most Recent Resistance Level193.69
P/B Ratio25.06
Upper Keltner187.12
P/S RatioInfinity
Lower Keltner155.52
Debt-to-Equity Ratio187.12
Next Earnings Date08/04/2026
Cash Surplus151.3M
Next Ex-Dividend DateUnknown

Revolution Medicines, Inc., a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company's research and development pipeline consist of RAS(ON) inhibitors that binds RAS variants to be used as monotherapy in combination with other RAS(ON) inhibitors and/or in combination with RAS companion inhibitors or other therapeutic agents, and RAS companion inhibitors to suppress cooperating targets and pathways that sustain RAS-addicted cancers. Its RAS(ON) inhibitors include daraxonrasib (RMC-6236), elironrasib G12C (RMC-6291) which is in early clinical development for the treatment of solid tumors, and zoldonrasib G12D (RMC-9805), which are in phase 3 registrational trial evaluating the combination of daraxonrasib with zoldonrasib in patients with 1L PDAC; and development candidates comprise RMC-5127 (G12V) which is in clinical trial, RMC-0708 (Q61H), that is in clinical trial; and RMC-8839 (G13C). Revolution Medicines, Inc. was incorporated in 2014 and is headquartered in Redwood City, California.

Revolution Medicines Inc In Our Stock Scanner

As of Jul 09, 2026
example chart graphic
Scan Name: Ascending TriangleScan Type: Chart Pattern Scans
As of ---
example chart graphic
Scan Name: Low Debt to Equity RatioScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Uptrending StocksScan Type: Chart Pattern Scans
As of ---
example chart graphic
Scan Name: Cash SurplusScan Type: Stock Fundamentals
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.

This site uses cookies to provide you with an optimal user experience. By using StockMarketGuides.com, you accept our use of cookies.